Author Page for Lin Wang

Safety and Cross-Reactive Immune Response Against the Omicron Variant of a Third Dose of CoronaVac, and Immune Persistence of Primary Immunization in Healthy Children and Adolescents: Interim Results from a Double-Blind, Randomised, Placebo-Controlled Phase 2 Clinical Trial

Number of pages: 35 Posted: 03 May 2022

Lei Wang, Zhiwei Wu, Zhifang Ying, Minjie Li, Yuansheng Hu, Qun Shu, Jing Li, Qingxia Ma, Hengming Zhang, Wenbin Jiao, Lin Wang, Yuliang Zhao and Qiang Gao

Sinovac Life Sciences Co., Ltd., Hebei Provincial Center for Disease Control and Prevention, National Institutes for Food and Drug Control, Hebei Provincial Center for Disease Control and Prevention, Sinovac Life Sciences Co., Ltd., Beijing Key Tech Statistics Technology Co., Ltd., Sinovac Life Sciences Co., Ltd., Zanhuang County Center for Disease Control and Prevention, Sinovac Life Sciences Co., Ltd., Zanhuang County Center for Disease Control and Prevention, Sinovac Life Sciences Co., Ltd., Hebei Provincial Center for Disease Control and Prevention and Sinovac Life Sciences Co., Ltd.

Downloads 179 (422,345)

Abstract:

2.

Six-Month Follow-Up of a Booster Dose of CoronaVac: Two Single-Centre, Double-Blind, Randomised, Placebo-Controlled Phase 2 Clinical Trials

Number of pages: 26 Posted: 22 Dec 2021

Qianqian Xin, Qianhui Wu, Xinhua Chen, Bihua Han, Chu Kai, Yan Song, Hui Jin, Panpan Chen, Wangying Lu, Tuantuan Yang, Minjie Li, Yuliang Zhao, Hong-Xing Pan, Hongjie Yu, Hongjie Yu and Lin Wang

Sinovac Life Sciences Co., Ltd., Fudan University, Fudan University - Key Laboratory of Public Health Safety, Hebei Provincial Center for Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Fudan University, affiliation not provided to SSRN, Hebei Provincial Center for Disease Control and Prevention, Hebei Provincial Center for Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Fudan University - Key Laboratory of Public Health SafetyFudan University - Shanghai Institute of Infectious Disease and Biosecurity and Sinovac Life Sciences Co., Ltd.

Downloads 132 (551,165)

Citation 1

Lin Wang

Sinovac Life Sciences Co., Ltd.

2

311

1

Scholarly Papers (2)

Safety and Cross-Reactive Immune Response Against the Omicron Variant of a Third Dose of CoronaVac, and Immune Persistence of Primary Immunization in Healthy Children and Adolescents: Interim Results from a Double-Blind, Randomised, Placebo-Controlled Phase 2 Clinical Trial

Abstract:

Six-Month Follow-Up of a Booster Dose of CoronaVac: Two Single-Centre, Double-Blind, Randomised, Placebo-Controlled Phase 2 Clinical Trials

Abstract: